Filing Flows › Cryoport (CYRX) › Q3 2026
Cryoport (CYRX) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Cryoport (CYRX) reported revenue of $50.2M for the third quarter 2026 (Q3 2026), +14% from a year earlier and +3% from the quarter before. Operating margin was -17.5%, net loss $10.9M (21.6% of revenue).
Cryoport, Q3 2026: revenue $50.2M (+14% year over year), operating margin -17.5%, net loss $10.9M, operating cash flow $5.2M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $50.2M | +3% | +14% |
| Operating profit | −$8.8M | — | — |
| Net earnings | −$10.9M | — | — |
| Operating cash flow | $5.2M | +361% | +138% |
What changed
Revenue was $50.2M in Q3 2026, up 14% year over year and up 3% from the previous quarter. BioLogistics Solutions was the largest line at 45% of revenue. BioLogistics Solutions added $3.1M year over year (up 16%), 52% of the total change.
Gross margin was 47.5%, down 0.8 points from Q3 2025. Operating costs exceeded revenue by $8.8M, an operating margin of -17.5%. Operating expenses grew 4% against revenue growth of 14%. The quarter ended with a net loss of $10.9M, wider than the previous quarter's $8.3M loss.
Operating cash flow was $5.2M (up 138% year over year). Non-cash charges added back $6.5M of depreciation and amortization and $2.3M of share-based compensation. Working capital and other items added $7.3M. Capital expenditures of $5.3M exceeded it, leaving free cash flow of −$40K.
Questions
What was Cryoport's revenue in the third quarter 2026?
Cryoport (CYRX) reported revenue of $50.2M for the third quarter 2026 (Q3 2026), +14% from a year earlier and +3% from the quarter before.
Was Cryoport profitable in the third quarter 2026?
Operating loss was $8.8M (-17.5% of revenue) and net loss $10.9M.
Source: Cryoport 10-Q on SEC EDGAR.